Antimullerian hormone and obesity: insights in oral contraceptive users

Contraception

Volumn 81, Issue 3, 2010, Pages 245-248

  Steiner, Anne Z ^a   Stanczyk, Frank Z ^b   Patel, Stan ^b   Edelman, Alison ^c  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Antimullerian hormone; Obesity; Oral contraceptives

Indexed keywords

ESTRADIOL; ETHINYLESTRADIOL PLUS LEVONORGESTREL; FOLLITROPIN; GONADOTROPIN; INHIBIN B; LUTEINIZING HORMONE; MUELLERIAN INHIBITING FACTOR;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; FEMALE; FOLLITROPIN BLOOD LEVEL; GRANULOSA CELL; HORMONAL THERAPY; HUMAN; LOW DRUG DOSE; LUTEINIZING HORMONE BLOOD LEVEL; MATERNAL AGE; MENSTRUAL CYCLE; OBESITY; ORAL CONTRACEPTION; OVULATION; PLETHYSMOGRAPHY;

ADOLESCENT; ADULT; ANTI-MULLERIAN HORMONE; BODY MASS INDEX; CONTRACEPTIVES, ORAL, COMBINED; ESTRADIOL; ETHINYL ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; INHIBINS; LEVONORGESTREL; LUTEINIZING HORMONE; OBESITY; REGRESSION ANALYSIS;

EID: 76049129852     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2009.10.004     Document Type: Article

References (19)

1. van Rooij I.A., Broekmans F.J., Scheffer G.J., et al. Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study. Fertil Steril 83 (2005) 979-987
2. van Rooij I.A., Broekmans F.J., te Velde E.R., et al. Serum anti-Mullerian hormone levels: a novel measure of ovarian reserve. Hum Reprod 17 (2002) 3065-3071
3. Fanchin R., Taieb J., Lozano D.H., Ducot B., Frydman R., and Bouyer J. High reproducibility of serum anti-Mullerian hormone measurements suggests a multi-staged follicular secretion and strengthens its role in the assessment of ovarian follicular status. Hum Reprod 20 (2005) 923-927
4. Hehenkamp W.J., Looman C.W., Themmen A.P., de Jong F.H., Te Velde E.R., and Broekmans F.J. Anti-Mullerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation. J Clin Endocrinol Metab 91 (2006) 4057-4063
5. Somunkiran A., Yavuz T., Yucel O., and Ozdemir I. Anti-Mullerian hormone levels during hormonal contraception in women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 134 (2007) 196-201
6. Visser J.F., de Jong F.H., Laven J.S.E., and Themmen A.P.N. Anti-Mullerian hormone: a new marker for ovarian function. Reproduc 131 (2006) 1-9
7. Freeman E.W., Gracia C.R., Sammel M.D., Lin H., Lim L.C., and Strauss III J.F. Association of anti-mullerian hormone levels with obesity in late reproductive-age women. Fertil Steril 87 (2007) 101-106
8. Su H.I., Sammel M.D., Freeman E.W., Lin H., Deblasis T., and Gracia C.R. Body size affects measures of ovarian reserve in late reproductive age women. Menopause 15 (2008) 857-861
9. Edelman A.B., Carlson N.E., Cherala G., et al. Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic-pituitary-ovarian activity. Contraception 80 (2009) 119-127
10. Arbo E., Vetori D.V., Jimenez M.F., Freitas F.M., Lemos N., and Cunha-Filho J.S. Serum anti-mullerian hormone levels and follicular cohort characteristics after pituitary suppression in the late luteal phase with oral contraceptive pills. Hum Reprod 22 (2007) 3192-3196
11. Streuli I., Fraisse T., Pillet C., Ibecheole V., Bischof P., and de Ziegler D. Serum antimullerian hormone levels remain stable throughout the menstrual cycle and after oral or vaginal administration of synthetic sex steroids. Fertil Steril 90 (2008) 395-400
12. van Disseldorp J., Faddy M.J., Themmen A.P., et al. Relationship of serum antimullerian hormone concentration to age at menopause. J Clin Endocrinol Metab 93 (2008) 2129-2134
13. Grossman M.P., Nakajima S.T., Fallat M.E., and Siow Y. Mullerian-inhibiting substance inhibits cytochrome P450 aromatase activity in human granulosa lutein cell culture. Fertil Steril 89 (2008) 1364-1370
14. Weenen C., Laven J.S., Von Bergh A.R., et al. Anti-Mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod 10 (2004) 77-83
15. Andersen C.Y., and Byskov A.G. Estradiol and regulation of anti-Mullerian hormone, inhibin-A, and inhibin-B secretion: analysis of small antral and preovulatory human follicles' fluid. J Clin Endocrinol Metab 91 (2006) 4064-4069
16. Andersen C.Y., and Lossl K. Increased intrafollicular androgen levels affect human granulosa cell secretion of anti-Mullerian hormone and inhibin-B. Fertil Steril 89 (2008) 1760-1765
17. Ledoux S., Campos D.B., Lopes F.L., Dobias-Goff M., Palin M.F., and Murphy B.D. Adiponectin induces periovulatory changes in ovarian follicular cells. Endocrinol 147 (2006) 5178-5186
18. Arita Y., Kihara S., Ouchi N., et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257 (1999) 79-83
19. Gracia C.R., Freeman E.W., Sammel M.D., Lin H., and Nelson D.B. The relationship between obesity and race on inhibin B during the menopause transition. Menopause 12 (2007) 559-566